Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 71 (2-3) , 322-334
- https://doi.org/10.1016/j.antiviral.2006.03.012
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol γ hypothesisAIDS, 2006
- Treatment for Adult HIV InfectionJAMA, 2004
- Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 InfectionNew England Journal of Medicine, 2004
- EmtricitabineDrugs, 2003
- AbacavirDrugs, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Clinical Pharmacokinetics of LamivudineClinical Pharmacokinetics, 1999
- Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogsBiochemical and Biophysical Research Communications, 1991
- Clinical Pharmacokinetics of ZidovudineClinical Pharmacokinetics, 1989
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987